Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
70,999.40
(
-2.85%
)
News Focus
News Focus
Post# of 447270
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 269
Posts 18893
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: Number sleven post# 398426

Monday, 01/16/2023 6:36:18 PM

Monday, January 16, 2023 6:36:18 PM

Post# of 447270
Denner joined the Ariad BOD in February 2014 and was elected Chairman of that Board in January 2016. It wasn’t mere coincidence that Takeda bought ARIA in light of the history you cite, sleven. The search committee chaired by Denner found a new CEO for ARIA who had years of experience with Takeda.

That scenario already suggests that MRK would be a candidate to buy Amarin, with KM having considerable experience with MRK, Zocor(statin) and ezetimibe. My PCP prescribes Zocor, Vascepa and ezetimibe for me.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News